FDA has approved MOVANTIKsup/sup (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist drug for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief and millions of patients are treated with them in the United States each year. They work by binding to mu-receptors in the central nervous system, ...
via Medindia Health News More READ
No comments:
Post a Comment